Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vi Polysaccharide Typhoid Vaccine in Hue City
NCT00131820Phase 4Completed
- Sponsor
- International Vaccine Institute
- Start
- Dec 2001
- Primary completion
- Jan 2007
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Phase 4, randomised trial of salmonella typhi capsular polysaccharide vaccine in typhoid fever (2 arms), sponsored by International Vaccine Institute. Primary endpoints: Logistic feasibility of mass typhoid immunization campaign and Knowledge, attitudes, beliefs and practices. Started Dec 2001; status: completed.
02
Drugs
salmonella typhi capsular polysaccharide vaccine
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT00131820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00131820.